The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells | Science Signaling

Lapatinib may boost the efficacy of protein-degrading drugs by blocking drug efflux pumps.
Source: Signal Transduction Knowledge Environment - Category: Science Source Type: news